Science was the name of the game in pharma drugs last year — literally. FDA-approved drug names in 2022 leaned heavily on science associations, according to experts. While that’s not unusual, in a year of fewer approvals than any in the past six years, the overall naming conventions more often...
News Ticker
- [ February 4, 2023 ] senior Associate I, Technical Services – Kite Pharma – El Segundo, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Quality Assurance Specialist III – NKGen Biotech – Santa Ana, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Engineer I/II (Pharma Operations) – Glaukos Corporation – San Clemente, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] First Look at Data on Biosense Webster’s Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023 Los Angeles Biotech News
- [ February 4, 2023 ] Age-related macular degeneration (AMD) market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others – Technavio Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
